Amsterdam institute for Immunology and Infectious diseases
AI&I news
From Lab to Startup: Alsya Affandi’s Faculty of Impact Experience in Cancer Therapy InnovationIn April 2026, dr. Affandi, a pioneering researcher-entrepreneur from the Amsterdam institute for Immunology and Infectious diseases, joined the Faculty of Impact with a bold vision: to turn his scientific breakthroughs in next-generation cancer therapies into real-world solutions.
Kick-off Meeting: AI&I Theme Immune Homeostasis “The Immune System Unchecked”In January 2026, the AI&I community gathered for the kick-off meeting of the Immune Homeostasis theme, “The Immune System Unchecked.” Organized by theme leaders Joep Grootjans, Jan Van den Bossche, and Jochem Bernink, the event brought together researchers from across Amsterdam UMC and beyond to foster collaboration and knowledge exchange on immune homeostasis and its disruptions. The meeting featured a strong representation from diverse research areas, including infectious diseases, cancer, and immune regulation.
Work Visit Grant / Meliawati Poniman’s Research on HCV mRNA Vaccine at Imperial College London The Amsterdam institute for Immunology and Infectious diseases (AI&I) is committed to supporting innovative research and fostering international collaboration. In 2025, the AI&I International Work Visit Grant enabled research technician Meliawati Poniman (Department of Medical Microbiology and Infection prevention, Amsterdam UMC) to spend 3.5 months as a Visiting Researcher at Imperial College London, under the supervision of Prof. Robin Shattock.
